Ticker Details
Rockwell Medical, Inc. (DE) Common Stock Rockwell Medical Inc is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism, and hemodialysis.
IPO Date:	February 1, 1998
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$31.3M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 3.52%
Avg Daily Range (30 D):	$0.02 | 2.44%
Avg Daily Range (90 D):	$0.03 | 3.01%

Institutional Daily Volume
Avg Daily Volume:	.33M
Avg Daily Volume (30 D):	.24M
Avg Daily Volume (90 D):	.55M

Trade Size
Avg Trade Size (Sh.):	250
Avg Trade Size (Sh.) (30 D):	431
Avg Trade Size (Sh.) (90 D):	328

Institutional Trades
Total Institutional Trades:	185
Avg Institutional Trade:	$1.17M
Avg Institutional Trade (30 D):	$M
Avg Institutional Trade (90 D):	$M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.46M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	30.67K

News

Aug 14, 2025 @ 10:21 AM Rockwell Medical Tops Q2 EPS View Source: Jesterai

Oct 9, 2024 @ 8:12 PM DaVita Stock Gains 47.3% Year to Date: What's Behi... Source: Zacks, Benzinga Contributor

May 14, 2024 @ 11:15 AM Rockwell Medical (RMTI) Reports Q1 Loss, Tops Reve... Source: Zacks Equity Research

Mar 26, 2024 @ 10:15 PM Rockwell Medical (RMTI) Increases Despite Market S... Source: Zacks Equity Research

Mar 21, 2024 @ 11:10 AM Rockwell Medical (RMTI) Q4 Earnings and Revenues B... Source: Zacks Equity Research

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.15	$-.04	$-.01
Diluted EPS	$-.15	$-.04	$-.01
Revenue	$67.68M	$17.34M	$18.35M
Gross Profit	$11.55M	$2.9M	$3.88M
Net Income / Loss	$-5.4M	$-1.61M	$-.55M
Operating Income / Loss	$-4.81M	$-1.48M	$-.4M
Cost of Revenue	$56.13M	$14.44M	$14.47M
Net Cash Flow	$-1.78M	$-1.1M	$-2.9M
PE Ratio

Splits
May 13, 2022	1:11